The Allstate Co. (NYSE:ALL) Stock Holdings Lessened by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp lessened its stake in shares of The Allstate Co. (NYSE:ALL) by 13.6% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 18,045 shares of the insurance provider’s stock after selling 2,838 shares during the period. OMERS ADMINISTRATION Corp’s holdings in Allstate were worth $3,479,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Apella Capital LLC boosted its position in shares of Allstate by 1.9% in the 4th quarter. Apella Capital LLC now owns 3,231 shares of the insurance provider’s stock valued at $623,000 after purchasing an additional 60 shares during the period. Intrust Bank NA boosted its holdings in shares of Allstate by 0.5% in the fourth quarter. Intrust Bank NA now owns 12,135 shares of the insurance provider’s stock worth $2,340,000 after buying an additional 61 shares during the period. Perigon Wealth Management LLC increased its position in shares of Allstate by 2.1% in the fourth quarter. Perigon Wealth Management LLC now owns 2,990 shares of the insurance provider’s stock worth $571,000 after acquiring an additional 62 shares in the last quarter. Mather Group LLC. raised its holdings in shares of Allstate by 1.7% during the fourth quarter. Mather Group LLC. now owns 3,616 shares of the insurance provider’s stock valued at $697,000 after acquiring an additional 62 shares during the period. Finally, Angeles Wealth Management LLC raised its holdings in shares of Allstate by 4.6% during the fourth quarter. Angeles Wealth Management LLC now owns 1,403 shares of the insurance provider’s stock valued at $270,000 after acquiring an additional 62 shares during the period. 76.47% of the stock is owned by institutional investors.

Allstate Stock Up 0.0%

ALL stock opened at $202.56 on Wednesday. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42. The firm has a market cap of $53.64 billion, a PE ratio of 11.92, a PEG ratio of 1.01 and a beta of 0.32. The Allstate Co. has a 1 year low of $156.66 and a 1 year high of $212.91. The company has a fifty day simple moving average of $199.22 and a 200 day simple moving average of $195.34.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share for the quarter, missing analysts’ consensus estimates of $3.98 by ($0.45). The company had revenue of $14.30 billion during the quarter, compared to analyst estimates of $16.41 billion. Allstate had a return on equity of 28.20% and a net margin of 7.28%. Allstate’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period in the prior year, the firm earned $5.13 EPS. Sell-side analysts anticipate that The Allstate Co. will post 18.74 EPS for the current fiscal year.

Allstate declared that its board has approved a share buyback plan on Wednesday, February 26th that permits the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization permits the insurance provider to reacquire up to 3% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its stock is undervalued.

Allstate Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th were given a dividend of $1.00 per share. The ex-dividend date was Monday, March 10th. This represents a $4.00 dividend on an annualized basis and a yield of 1.97%. This is a boost from Allstate’s previous quarterly dividend of $0.92. Allstate’s dividend payout ratio is presently 27.32%.

Analyst Ratings Changes

Several research firms have weighed in on ALL. Argus upgraded shares of Allstate from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. JPMorgan Chase & Co. lifted their price target on Allstate from $217.00 to $222.00 and gave the company an “overweight” rating in a report on Tuesday, April 8th. Raymond James reissued a “strong-buy” rating and issued a $250.00 price objective (up from $240.00) on shares of Allstate in a research note on Monday, May 5th. Wells Fargo & Company lowered their target price on Allstate from $200.00 to $197.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 6th. Finally, StockNews.com upgraded shares of Allstate from a “hold” rating to a “buy” rating in a report on Thursday, May 1st. One research analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Allstate currently has an average rating of “Moderate Buy” and a consensus target price of $225.20.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.